These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Theory of antimotion sickness drug mechanisms. Wood CD; Graybiel A Aerosp Med; 1972 Mar; 43(3):249-52. PubMed ID: 4402925 [No Abstract] [Full Text] [Related]
5. Further experiments on the prevention of motion sickness. GLASER EM; HERVEY GR Lancet; 1952 Mar; 1(6706):490-2. PubMed ID: 14898786 [No Abstract] [Full Text] [Related]
6. Stimulation of the semicircular canals via the rotary chair as a means to test pharmacologic countermeasures for space motion sickness. Dornhoffer J; Chelonis JJ; Blake D Otol Neurotol; 2004 Sep; 25(5):740-5. PubMed ID: 15354005 [TBL] [Abstract][Full Text] [Related]
7. The prevention of seasickness with hyoscine, benadryl, and phenergan. GLASER EM; HERVEY GR Lancet; 1951 Oct; 2(6687):749-53. PubMed ID: 14874498 [No Abstract] [Full Text] [Related]
8. Motion illness. Hervey GR Trans Med Soc Lond; 1984-1985; 101():14-20. PubMed ID: 6152833 [No Abstract] [Full Text] [Related]
9. [Prevention and treatment of motion sickness]. Marks E; Swiecicki W Wiad Lek; 1974 Jan; 27(1):37-42. PubMed ID: 4152152 [No Abstract] [Full Text] [Related]
10. [Motion sickness and its treatment (author's transl)]. Petrin A Schweiz Rundsch Med Prax; 1974 Jan; 63(3):79-81. PubMed ID: 4153225 [No Abstract] [Full Text] [Related]
11. Various anti-motion sickness drugs and core body temperature changes. Cheung B; Nakashima AM; Hofer KD Aviat Space Environ Med; 2011 Apr; 82(4):409-15. PubMed ID: 21485398 [TBL] [Abstract][Full Text] [Related]
13. Treatment of severe motion sickness with antimotion sickness drug injections. Graybiel A; Lackner JR Aviat Space Environ Med; 1987 Aug; 58(8):773-6. PubMed ID: 3632537 [TBL] [Abstract][Full Text] [Related]
14. Scopolamine for preventing and treating motion sickness. Spinks AB; Wasiak J; Villanueva EV; Bernath V Cochrane Database Syst Rev; 2004; (3):CD002851. PubMed ID: 15266468 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate. Golding JF; Stott JR Br J Clin Pharmacol; 1997 Jun; 43(6):633-7. PubMed ID: 9205824 [TBL] [Abstract][Full Text] [Related]
16. Prevention of experimental motion sickness by scopolamine absorbed through the skin. Graybiel A; Knepton J; Shaw J Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234 [TBL] [Abstract][Full Text] [Related]
18. Promethazine as a motion sickness treatment: impact on human performance and mood states. Cowings PS; Toscano WB; DeRoshia C; Miller NE Aviat Space Environ Med; 2000 Oct; 71(10):1013-22. PubMed ID: 11051308 [TBL] [Abstract][Full Text] [Related]
19. Effects of motion sickness and antimotion sickness drugs on gastric function. Stewart JJ; Wood MJ; Wood CD; Mims ME J Clin Pharmacol; 1994 Jun; 34(6):635-43. PubMed ID: 8083395 [TBL] [Abstract][Full Text] [Related]
20. Airsickness prevention in helicopter passengers. Estrada A; LeDuc PA; Curry IP; Phelps SE; Fuller DR Aviat Space Environ Med; 2007 Apr; 78(4):408-13. PubMed ID: 17484344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]